Concepts (33)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 3 | 2012 | 195 | 0.650 |
Why?
|
| Tamoxifen | 2 | 2012 | 17 | 0.440 |
Why?
|
| Aromatase Inhibitors | 1 | 2012 | 4 | 0.370 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2012 | 10 | 0.360 |
Why?
|
| Receptors, Progesterone | 1 | 2010 | 17 | 0.320 |
Why?
|
| Postmenopause | 1 | 2010 | 26 | 0.320 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 39 | 0.320 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 105 | 0.310 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2012 | 40 | 0.170 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2012 | 7 | 0.090 |
Why?
|
| Ovariectomy | 1 | 2012 | 19 | 0.090 |
Why?
|
| Medication Adherence | 1 | 2012 | 29 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 116 | 0.090 |
Why?
|
| Female | 3 | 2012 | 6974 | 0.080 |
Why?
|
| Night Blindness | 1 | 2010 | 2 | 0.080 |
Why?
|
| Fenretinide | 1 | 2010 | 5 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2010 | 166 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 726 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2010 | 817 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2007 | 4 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2007 | 5 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2007 | 4 | 0.060 |
Why?
|
| Humans | 3 | 2012 | 12240 | 0.060 |
Why?
|
| Receptor, ErbB-2 | 1 | 2007 | 32 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2007 | 86 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 99 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 2152 | 0.060 |
Why?
|
| Adult | 1 | 2010 | 3557 | 0.050 |
Why?
|
| Middle Aged | 1 | 2010 | 4043 | 0.040 |
Why?
|
| Aged | 1 | 2010 | 4000 | 0.040 |
Why?
|
| Trastuzumab | 1 | 2007 | 16 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 53 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2007 | 40 | 0.020 |
Why?
|